Nobelpharma America on X: "We're excited to announce that HYFTOR™ (sirolimus topical gel) 0.2% is now approved by the FDA! Learn more: https://t.co/VonIUt4ZVi https://t.co/P1WjZ6J4Xs" / X
Home - HYFTOR® Patient Site
Learn more at www.HYFTOR.com
Hyftor Topical Gel Now Available for TSC-Associated Facial Angiofibroma
About HYFTOR - HYFTOR® Patient Site
Sirolimus gel provides breakthrough treatment for TSC
Sirolimus - Wikipedia
China Customized Sirolimus Topical Gel Reference Listed Drug Suppliers, Manufacturers - Factory Direct Price - TOSUN
Improvement of tuberous sclerosis complex (TSC) skin tumors during long-term treatment with oral sirolimus - ScienceDirect
Efficacy and Safety of Topical Sirolimus Therapy for Facial Angiofibromas in the Tuberous Sclerosis Complex: A Randomized Clinical Trial | Semantic Scholar
Long‐term treatment of cutaneous manifestations of tuberous sclerosis complex with topical 1% sirolimus cream: A prospective study of 25 patients | Semantic Scholar
These highlights do not include all the information needed to use HYFTOR™ safely and effectively. See full prescribing information for HYFTOR. HYFTOR™ (sirolimus topical gel) Initial U.S. Approval: 1999
Efficacy and Safety of Topical Rapamycin in Patients With Facial Angiofibromas Secondary to Tuberous Sclerosis Complex: The TREATMENT Randomized Clinical Trial. - Abstract - Europe PMC
![PDF] Sirolimus Gel Treatment vs Placebo for Facial Angiofibromas in Patients With Tuberous Sclerosis Complex: A Randomized Clinical Trial | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/54f9e54723a39a55b43d74e366e743df79c21bd7/6-Figure3-1.png "PDF] Sirolimus Gel Treatment vs Placebo for Facial Angiofibromas in Patients With Tuberous Sclerosis Complex: A Randomized Clinical Trial | Semantic Scholar")
PDF] Sirolimus Gel Treatment vs Placebo for Facial Angiofibromas in Patients With Tuberous Sclerosis Complex: A Randomized Clinical Trial | Semantic Scholar
Hyftor (Sirolimus): Dosage, Uses, Side Effects & Reviews
Polymeric micelle formulations for the cutaneous delivery of sirolimus: A new approach for the treatment of facial angiofibromas in tuberous sclerosis complex - ScienceDirect
Sirolimus Topical Cream Compounded
Home - HYFTOR® HCP Site
Safety and Efficacy of the Sirolimus Gel for TSC Patients With Facial Skin Lesions in a Long-Term, Open-Label, Extension, Uncontrolled Clinical Trial | Dermatology and Therapy
New Breakthrough in Treatment for Rare Skin Condition - ResOU
First Topical Therapy for Facial Angiofibroma Nabs FDA Approval | MedPage Today
Topical Rapamycin for Facial Angiofibromas in a Child with Tuberous Sclerosis Complex (TSC): A Case Report and Long-Term Follow-up. - Abstract - Europe PMC
Hepcvel Ayurvedic Sirolimus Tablets, for Anti-Infective, Gel
Sirolimus gel provides breakthrough treatment for TSC
